TESSA™ technology provides a scalable process for manufacturing gene therapies, accelerating the production of large quantities of therapeutic DNA required to treat patients in need
New data published in Nature Communications supports the benefits of this technology
PR Newswire
PHILADELPHIA, March 7, 2022